INTERNATIONAL PATENT: MEMORIAL SLOAN-KETTERING CANCER CENTER, MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES, SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH, LI, YUEMING FILES APPLICATION FOR "2-(TERT-BUTYL)-4-METHYLPHENYL APPENDED 1,4-DIAZEPANE BASED NOVEL TFEB ACTIVATING COMPOUNDS AS AUTOPHAGY MODULATORS FOR NEURODEGENERATIVE DISORDERS INCLUDING ALZHEIMER'S DISEASE (AD)"

GENEVA, Oct. 20 -- MEMORIAL SLOAN-KETTERING CANCER CENTER (1275 York AvenueNew York, New York 10065), MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (1275 York AvenueNew York, New York 10065), SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (1275 York AvenueNew York, New York 10065), LI, Yueming (c/o MEMORIAL SLOAN KETTERING CANCER CENTER1275 York AvenueNew York, New York 10065) filed a patent application (PCT/US2025/024325) for "2-(TERT-BUTYL)-4-METHYLPHENYL APPENDED 1,4-DIAZEPANE BASED NOVEL TFEB ACTIVATING COMPOUNDS AS AUTOPHAGY MODULATORS FOR NEURODEGENERATIVE DISORDERS INCLUDING ALZHEIMER'S DISEASE (AD)" on Apr 11, 2025. With publication no. WO/2025/217552, the details related to the patent application was published on Oct 16, 2025.

N...